Suchergebnisse - "Seo, Jong Won"

PubPharm (16)

1

Incidence of colonoscopy-related perforation and risk factors for poor outcomes : 3-year results from a prospective, multicenter registry (with videos)

enthalten in: Surgical endoscopy | 2023

von Lee, J. | Lee, Y. | Seo, J. | +13

2

Incidence of colonoscopy-related perforation and risk factors for poor outcomes: 3-year results from a prospective, multicenter registry (with videos)

enthalten in: Surgical endoscopy and other interventional techniques | 2023

von Lee, J. | Lee, Y. | Seo, J. | +12

3

Incidence of colonoscopy-related perforation and risk factors for poor outcomes: 3-year results from a prospective, multicenter registry (with videos)

enthalten in: Surgical endoscopy | 2023

von Lee, J. | Lee, Y. | Seo, J. | +12

4

Diabetes Prediction methods using clinical and genetic Risk score in Korean and method for suggesting diagnosis related to Diabetes

enthalten in: Europäisches Patentamt | 2022

von SEO JONG WON | LEE EUN SOL

5

Neurovascular Disease Prediction methods using clinical and genetic Risk score in Korean and method for suggesting diagnosis related to Coronary Disease

enthalten in: Europäisches Patentamt | 2022

von SEO JONG WON | LEE EUN SOL

6

Hypertension Prediction methods using clinical and genetic Risk score in Korean and method for suggesting diagnosis related to Hypertension

enthalten in: Europäisches Patentamt | 2022

von SEO JONG WON | LEE EUN SOL

7

Coronary Disease Prediction methods using clinical and genetic Risk score in Korean and method for suggesting diagnosis related to Coronary Disease

enthalten in: Europäisches Patentamt | 2021

von SEO JONG WON | LEE EUN SOL

8

Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn's disease

enthalten in: Intestinal research | 2021

von Seo, J. | Kim, E. | Han, M. | +1

9

Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer

enthalten in: Anticancer research | 2014

von Lee, S. | Seo, J. | Chae, Y. | +7

10

Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate

enthalten in: International journal of hematology | 2013

von Lee, Y. | Moon, J. | Shin, H. | +4